Reasons for the Decline of AstraZeneca PLC (AZN) in Q4
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Astrazeneca Plc (AZN)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
AstraZeneca PLC (NASDAQ:AZN) Q4 2023 Earnings Call Transcript
AstraZeneca PLC misses on earnings expectations. Reported EPS is $0.73 EPS, expectations were $0.75.
5 Best Foreign Dividend Stocks To Invest In
In this article, we discuss 5 best foreign dividend stocks to invest in.
Should You Add AstraZeneca PLC (AZN)?
ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
16 Most Promising Dividend Stocks According to Analysts
In this article, we discuss 16 most promising dividend stocks according to analysts.
5 Best Foreign Stocks With Dividends
Yet another Canadian dividend stock in our list of the best foreign stocks with dividends, Cenovus Energy Inc (NYSE:CVE) came on the radar of Goldman Sachs earlier this month as the firm added the stock...
13 Most Promising Healthcare Stocks According to Analysts
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
11 Best European Dividend Stocks to Buy
European equities were laggards when compared to US stocks in 2023 as economic activity in the Eurozone continues to contract.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
